<DOC>
	<DOCNO>NCT02646930</DOCNO>
	<brief_summary>Background : Embryo quality know important determinant predict implantation pregnancy rate IVF patient , however , role uterine integrity endometrial receptivity overlook . Chronic endometritis ( CE ) inflammation endometrium diagnose presence plasma cell endometrial stroma . There census definition CE , current literature impact CE reproductive outcome controversial consist retrospective study small sample size . Although presumption CE relate poor IVF outcome , belief proven . Design : Prospective cohort study Setting : Infertility clinic 2 academic medical center Patients : Patients age ≥ 21 ≤ 35 year old undergoing first IVF cycle invite participate . Main Outcome Measures : The primary outcome ongoing pregnancy 12 week estimate gestational age ( EGA ) previously document fetal cardiac motion . Secondary outcome include pregnancy loss rate define chemical pregnancy , blight ovum loss fetal cardiac motion 12 week EGA . Materials Methods : The cycle prior IVF , patient undergo in-office endometrial biopsy cycle day 19-24 . Samples stain CD138 number plasma cell quantify . The number plasma cell sample yield best sensitivity specificity pregnancy determine Receiver-Operator-Curve . This number use dichotomous variable assign category `` positive CE '' `` negative CE . '' Pregnancy miscarriage rate determine positive negative CE sample Chi Square Analysis . A secondary sub analysis perform determine pregnancy miscarriage rate patient decline participate study . Expected Results : The investigator hypothesize high rate CE find woman fail conceive IVF subsequent first-trimester miscarriage .</brief_summary>
	<brief_title>Chronic Endometritis IVF</brief_title>
	<detailed_description />
	<mesh_term>Endometritis</mesh_term>
	<criteria>age ≥ 21 ≤ 35 year old undergoing first IVF cycle diagnosis ovulatory dysfunction , pelvic factor , male factor , cervical factor unexplained infertility BMI &gt; 40 kg/m2 , antimullerian hormone ( AMH ) &lt; 1.0 ng/mL antral follicle count &lt; 10 previous endometrial ablation previous uterine artery embolization presence type 0 , 1 , 2 , 3 fibroid tumor presence type 4 fibroid tumor mean diameter &gt; 4 cm presence uterine anomaly arcuate configuration presence endometrial polyp endometrial synechiae presence hydrosalpinx hysterosalpingography ultrasound positive gonorrhea chlamydia DNA test Patients chronic glucocorticoid ( except nasal preparation ) , use glucocorticoid assist hatch exclude . Patients monoclonal antibody preparation direct TNFα exclude . Postenrollment exclusion include patient receive antibiotic , except prophylaxis transvaginal oocyte retrieval ( TVOR ) glucocorticoid , except nasal preparation , time endometrial biopsy initial transvaginal ultrasound ( TVUS ) pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>chronic endometritis</keyword>
	<keyword>invitro fertilization</keyword>
	<keyword>spontaneous abortion</keyword>
</DOC>